Stefano Elli Selected Research

enisamium

9/2021	Enisamium Inhibits SARS-CoV-2 RNA Synthesis.
1/2021	Enisamium is an inhibitor of the SARS-CoV-2 RNA polymerase and shows improvement of recovery in COVID-19 patients in an interim analysis of a clinical trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stefano Elli Research Topics

Disease

6	Infections 01/2022 - 07/2015
4	Human Influenza (Influenza) 09/2021 - 10/2013
3	COVID-19 07/2022 - 01/2021
2	Sepsis (Septicemia) 07/2022 - 07/2015
2	Hemorrhage 01/2022 - 11/2021
2	Inflammation (Inflammations) 01/2022 - 01/2020
2	Respiratory Insufficiency (Respiratory Failure) 11/2021 - 11/2019
2	Venous Thrombosis (Deep-Vein Thrombosis) 09/2021 - 09/2020
2	Virus Diseases (Viral Diseases) 12/2020 - 07/2014
2	Neoplasms (Cancer) 01/2020 - 11/2016
2	Pain (Aches) 11/2019 - 10/2015
1	Thrombosis (Thrombus) 07/2022
1	Thrombocytopenia (Thrombopenia) 01/2022
1	Interstitial Cystitis (Interstitial Cystitis, Chronic) 01/2022
1	Wounds and Injuries (Trauma) 11/2021
1	Coronavirus Infections 09/2021
1	Influenza in Birds (Avian Flu) 01/2021
1	Severe Acute Respiratory Syndrome 12/2020
1	Bacterial Infections (Bacterial Infection) 11/2020
1	Flushing 09/2020
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Suppuration 10/2018
1	Vomiting 04/2017
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 04/2017
1	Shock 01/2008

Drug/Important Bio-Agent (IBA)

3	Heparin (Liquaemin)FDA LinkGeneric 01/2022 - 11/2016
3	Antiviral Agents (Antivirals)IBA 09/2021 - 12/2020
2	Pharmaceutical PreparationsIBA 01/2022 - 10/2017
2	enisamiumIBA 09/2021 - 01/2021
2	DNA-Directed RNA Polymerases (RNA Polymerase)IBA 09/2021 - 01/2021
2	nasIBA 01/2021 - 10/2017
2	heparanaseIBA 01/2020 - 11/2016
2	Polysaccharides (Glycans)IBA 07/2014 - 10/2013
1	AnticoagulantsIBA 01/2022
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2022
1	Pentosan Sulfuric Polyester (Pentosan Polysulfate)FDA Link 01/2022
1	VaccinesIBA 09/2021
1	remdesivirIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	HydrolasesIBA 01/2021
1	GlycoconjugatesIBA 01/2021
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 01/2021
1	Angiotensin-Converting Enzyme 2IBA 12/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2020
1	Carbapenems (Carbapenem Antibiotics)IBA 11/2020
1	Saline SolutionIBA 09/2020
1	Heparitin Sulfate (Heparan Sulfate)IBA 01/2020
1	EnzymesIBA 01/2020
1	Dobutamine FDA LinkGeneric 10/2018
1	AcidsIBA 04/2017
1	roneparstatIBA 11/2016
1	Uronic AcidsIBA 11/2016
1	Viral HemagglutininsIBA 07/2014
1	SolutionsIBA 10/2013

Therapy/Procedure

4	Catheters 07/2022 - 07/2015
2	Cannula 07/2022 - 11/2021
2	Therapeutics 11/2020 - 11/2019
1	Extracorporeal Membrane Oxygenation 11/2021
1	Continuous Positive Airway Pressure 11/2019
1	Artificial Respiration (Mechanical Ventilation) 10/2018
1	Length of Stay 10/2018
1	Enteral Nutrition (Feeding, Tube) 04/2017
1	Critical Care (Surgical Intensive Care) 10/2015
1	Extracorporeal Circulation 01/2008